All responses to bladder cancer

Written by: Dr. Miguel Ramírez Backhaus
Published: | Updated: 24/02/2018
Edited by: Top Doctors®

The bladder tumor is caused by the uncontrolled proliferation of a group of mucosal cells, so-called transitional cell.

The tumor may be confined to the mucosa or can infiltrate the next layer, muscle. According to the aggressiveness of the tumor, we can classify them into low-grade tumors (less aggressive) or more aggressive tumors.

 

Risk factors for bladder cancer

Smoking is the most common bladder cancer risk factor. Therefore, if a patient is diagnosed with this cancer it is of vital importance to abandon the consumption of snuff. Working with enamels, paint or varnish is also a risk factor.

 

Common signs and symptoms of bladder cancer

The most common and visible sign of bladder cancer is painless hematuria, blood in the urine. Sometimes, the tumors do not produce enough blood to the viewing patient (microscopic hematuria) own and can only be detected with the aid of a microscope. It is therefore appropriate that, smokers and workers in contact with the substances described above, come urological annual review with urinalysis and ultrasound.

On the other hand, the appearance of blood in the urine does not necessarily develop bladder cancer, but can be caused by infections, kidney stones, drug or overexertion. However, irritation during urination, urgency and constant urination can be symptoms of bladder cancer.

 

Diagnosis

After ultrasound and urinalysis (sediment and cytology) cystoscopy is necessary. The UROSALUD center has a flexible cystoscope, which allows the inside of the bladder and urethra using a flexible silicone telescope outpatients. This procedure minimizes the hassles of test done in the office. The scope is inserted through the urethra, prior administration of lubricant gel with antiseptic and anesthetic to minimize potential inconveniences. During cystoscopy, we examine in detail the urethra, prostate, and bladder.

 

Treatments

Depending on the type of cancer or bladder tumor urosalud will recommend one of the following alternatives:Transurethral resection of Injury Bladder (TURB): A non-invasive surgery performed transurethral way to remove blood and possible tumor lesion. There are less than 10% risk of infection or injury with this technique that is easily corrected.

  • Intravesical therapy: This is local chemotherapies or immunotherapies for noninvasive tumors urosalud have the most advanced thermotherapy or electrotherapy modalities to prevent relapse of these tumors.
  • Excision and reconstruction of the bladder or radical cystectomy: This involves the complete removal of the bladder and surrounding lymph nodes (prostate in men and women the uterus, fallopian tubes, ovaries and cervix). Once bladder removed will create a new way for urine to be expelled from the body. This procedure can be done either by classic open approach or by minimally invasive laparoscopic surgery.
  • Chemotherapy drugs are used, intravenously, which are used to treat cancer is metastatic systematically when
  • Conservation therapy Bladder is a therapy based on the use of chemotherapy and close monitoring with CT and cystoscopy in surgery that preserves the bladder to a subgroup of patients with invasive bladder cancer.

 

*Translated with Google translator. We apologize for any imperfection

By Dr. Miguel Ramírez Backhaus
Urology

Dr. Ramirez Backhaus is a renowned specialist in Urology. Porla Graduate University of Navarre and Doctor "cum laude" from the University of Valencia. Formed in the Serviciod and Urology Hospital La Fe, he completed his training doing a fellow in laparoscopic surgery in the urology department of Leipzig, where he also worked as a urologist. He returned to the Faith Hospital and later moved to the Hospital de la Ribera, where he pioneered the application of pelvic laparoscopy. He collaborates in several projects multicentre international scientific research. He is a member of the Editorial Board of the journal "Urology Spanish Files", "urological Minutes", "BMC Urology" and "International Journal of Urology". He has made several international stays in various urological centers in urooncología related, highlight MSKCC in New York. It has also made 3 postgraduate masters, among which masters in molecular oncology at the CNIO. He is currently co-director of Urosalud, the unit of Urology Hospital Casa de Salud de Valencia.

*Translated with Google translator. We apologize for any imperfection

View Profile

Overall assessment of their patients


TOPDOCTORS utiliza cookies propias y de terceros para facilitar su experiencia como usuario de nuestra web y captar datos estadísticos mediante el análisis de sus datos de navegación. Si usted continúa con la navegación, entendemos que nos ofrece su consentimiento para el uso de cookies. Puede cambiar la configuración de cookies u obtener más información here.